Pierre LaPalme
Président chez GLyPharma Therapeutic, Inc.
Postes actifs de Pierre LaPalme
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
GLyPharma Therapeutic, Inc.
 GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology GLyPharma Therapeutic, Inc. develops oncology therapeutic treatment. It engages in the development of the clinical efficacy of FE 203799, a novel proprietary Glucagon-Like Peptide-2(GLP-2) analogue exerting unique pharmacological effects in a first-in-class, meaningful indication for patients with hematological malignancies receiving myelotoxic therapies. The company was founded in August 2012 and is headquartered in Montreal, Canada. | Président | 01/01/2012 | - |
Historique de carrière de Pierre LaPalme
Anciens postes connus de Pierre LaPalme
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INSYS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/03/2011 | 05/06/2019 |
| Independent Dir/Board Member | 01/03/2011 | 05/06/2019 | |
| MEDEXUS PHARMACEUTICALS INC. | Président | 10/12/2013 | 19/12/2018 |
| Independent Dir/Board Member | 10/12/2013 | 19/12/2018 | |
| Pediapharm, Inc. /Old/ | Président | 01/12/2013 | 01/12/2018 |
| BIOMARIN PHARMACEUTICAL INC. | Directeur/Membre du Conseil | 01/01/2015 | 01/06/2016 |
| Président | 01/08/2004 | 01/06/2015 | |
| Independent Dir/Board Member | 01/08/2004 | 10/05/2012 | |
| AETERNA ZENTARIS INC. | Directeur/Membre du Conseil | 11/12/2009 | 01/01/2016 |
| Independent Dir/Board Member | 08/12/2009 | 01/01/2016 | |
Bioxel Pharma, Inc.
 Bioxel Pharma, Inc. BiotechnologyHealth Technology Bioxel Pharma, Inc. develops pharmaceutical products used in the treatment of cancer, multiple sclerosis and Alzheimers. The company is engaged in the development, production and distribution of therapeutically active taxanes isolated from the Canadian yew. Bioxel Pharma was founded on July 13, 1995 and is headquartered in Quebec, Canada. | Président | 01/01/2002 | 01/01/2009 |
| Sciele Pharmaceuticals, Inc. | Directeur/Membre du Conseil | 01/01/2000 | 01/01/2008 |
Shionogi Pharma, Inc.
 Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Président | 01/04/2000 | 01/01/2008 |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░░ ░░░░░ | ░░░░░ ░ ░░░░░░░░░ | - | - |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ | - | ░░░░░░░░░░ | |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Statistiques
Internationale
| Etats-Unis | 11 |
| Canada | 10 |
| France | 2 |
Opérationnelle
| Director/Board Member | 9 |
| Chairman | 7 |
| Independent Dir/Board Member | 4 |
Sectorielle
| Health Technology | 12 |
| Commercial Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| AETERNA ZENTARIS INC. | Health Technology |
| SANOFI | Health Technology |
| MEDEXUS PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 17 |
|---|---|
| Ciba-Geigy Corp. | Health Technology |
Shionogi Pharma, Inc.
Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Health Technology |
Bioxel Pharma, Inc.
Bioxel Pharma, Inc. BiotechnologyHealth Technology Bioxel Pharma, Inc. develops pharmaceutical products used in the treatment of cancer, multiple sclerosis and Alzheimers. The company is engaged in the development, production and distribution of therapeutically active taxanes isolated from the Canadian yew. Bioxel Pharma was founded on July 13, 1995 and is headquartered in Quebec, Canada. | Health Technology |
BioCapital Investment Advisors, Inc.
 BioCapital Investment Advisors, Inc. Investment ManagersFinance Montréal-based BioCapital Investment Advisors, Inc. manages the BioCapital health technology mutual fund family. | Finance |
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Health Technology |
| Confab, Inc. | Consumer Non-Durables |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Commercial Services |
Algorithme Pharma, Inc.
 Algorithme Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Algorithme Pharma, Inc. engages in the provision of cal research services. The company was founded by Louis Caillé in 1992 and is headquartered in Laval, Canada. | Commercial Services |
| Canada's Research Based Pharmaceutical Cos. | |
| North America Ethypharm, Inc. | |
| Rhone-Poulenc Canada, Inc. | |
| Pharmaceutical Manufacturers Association of Canada | |
| Pediapharm, Inc. /Old/ | Health Technology |
INSYS Therapeutics, Inc.
 INSYS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ. | Health Technology |
| Rhone-Poulenc Pharmaceuticals, Inc. | |
GLyPharma Therapeutic, Inc.
GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology GLyPharma Therapeutic, Inc. develops oncology therapeutic treatment. It engages in the development of the clinical efficacy of FE 203799, a novel proprietary Glucagon-Like Peptide-2(GLP-2) analogue exerting unique pharmacological effects in a first-in-class, meaningful indication for patients with hematological malignancies receiving myelotoxic therapies. The company was founded in August 2012 and is headquartered in Montreal, Canada. | Health Technology |
| Sciele Pharmaceuticals, Inc. |
- Bourse
- Insiders
- Pierre LaPalme
- Expérience
